Connect with us

COVID-19

Fashion Designer, Alber Elbaz Dies in Paris Aged 59

Published

on

Fashion Designer, Alber Elbaz Dies in Paris Aged 59

Producer: Eunice Johnson

Designer Alber Elbaz, who worked at some of France’s best-known fashion houses, has died in Paris aged 59.
His business partner Johann Rupert said Elbaz had died from COVID-19 in Paris, France.
From 2001, Elbaz was Artistic Director at Lanvin, where he was credited with rejuvenating the brand until he was sacked in 2015.
Elbaz who was famously known for “inclusive vision of fashion” revived lanvin by transforming it to focus mainly on women’s fashion.

YOU CAN FOLLOW US ON FACEBOOK

His dresses were favored by hollywood actresses, including Natalie Portman and Meryl Streep who wore one of his gowns, in gold lamé, when accepting the Oscar for her portrayal of Margaret Thatcher in the Iron Lady in 2012.
He also recently launched his own label, AZ Factory.
He was rewarded with many of the fashion industry’s top prizes, including an award named for his old mentor, Geoffrey Beene.
In 2016, he was made a member of the French legion of honour, the country’s most prestigious fashion award.

Read Also:

Scottish Pop Vocalist Known as Les McKeown is Dead

African nations sitting on debt volcano

Ikorudu Bois Nominated for 2021 Nickelodeon Kids Choice Award

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

COVID-19

U.S Approves Pfizer COVID Booster for The Elderly and High-Risk

Published

on

U.S Approves Pfizer COVID Booster for The Elderly and High-Risk

The U.S has authorised the administration of boosters of the Pfizer-Biontech Covid-19 vaccine for people aged over 65, as well as adults at high risk of severe disease and those in high-exposure jobs.

The announcement means a significant part of the US population – amounting to tens of millions of Americans – are now eligible for a third shot six months after their second.

The decision was expected and came after an independent expert panel convened by the regulatory agency last week voted in favour of recommending the move.

Watch Our Youtube Videos

The panel, however, rejected an initial plan by the white house to fully approve Pfizer boosters for everyone aged 16 and over, in what amounted to a rare rebuke of President Joe Biden’s administration.

Pfizer Covid-19 boosters are currently being debated by a separate body of experts convened by the centers for disease control and prevention, which may recommend further specifics about recipients of the vaccine.

Read Also:

President Biden Pledges 500m More Vaccine Doses to Developing World

Japan Detects More Moderna Vaccine Contamination

 

Continue Reading

COVID-19

India Resumes Export of Covid-19 Vaccine from October

Published

on

India Resumes Export of Covid-19 Vaccine from October

India will resume exporting Covid-19 vaccines from October, five months after it stopped sending supplies abroad in the face of a deadly wave of infections, the health minister said on Monday.

The world’s largest vaccine producer had halted exports in April, when a virus surge in India pushed the healthcare system to breaking point and there was a huge demand for jabs.

Health Minister Mansukh Mandaviya said more than 300 million vaccine doses would be produced in October and one billion in the last three months of the year.

Follow us on Facebook

“India will be resuming export of vaccines in order to fulfill the commitment of India towards Covax. The surplus supply of vaccines will be used to fulfill our commitment towards the world for the collective fight against Covid-19”, Mandaviya said in a statement.

India wants to vaccinate its adult population by the end of 2021. It has given more than 818 million doses of the three approved jabs since the beginning of the vaccination drive in January. On Friday, it administered a record-breaking 20 million doses, surpassing the country’s previous best daily tally of more than 13 million jabs on 27 August.

Read Also:

Court Orders Resident Doctors to Call Off Strike

AU Rolls Out 400m Vaccine Doses to Member States

Continue Reading

COVID-19

Pfizer Says Its Covid-19 Jab Safe for Children Aged 5-11

Published

on

Pfizer Says Its Covid-19 Jab Safe for Children Aged 5-11

Pfizer and Biontech on Monday said trial results showed their Coronavirus vaccine was safe and produced a robust immune response in children aged five to 11, adding that they would seek regulatory approval shortly.

The vaccine would be administered at a lower dosage than for people over 12, they said.

They plan to submit their data to regulatory bodies in the European Union, the united states and around the world “as soon as possible”.

Follow us on Facebook

The trial results are the first of their kind for children under 12, with a Moderna trial for six-11-year-olds still ongoing.

Both the Pfizer and Moderna jabs are already being administered to adolescents over 12 and adults in countries around the globe.

Although children are considered less at risk of severe cases of Covid-19, there are concerns that the highly contagious delta variant could lead to more serious cases.

Inoculating children is also seen as key to keeping schools open and helping end the pandemic.

Read Also:

Nigerian Doctor Helps Pfizer Develop First Effective COVID-19 Vaccine

NPHCDA Begins Online Registration Of Nigerians For COVID-19 Vaccination

Continue Reading

Trending